Asset Details
Do you wish to reserve the book?
Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia
Do you wish to request the book?
Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Free erythrocyte protoporphyrin fluorescence as an underrecognized prognostic marker of mortality in community-acquired pneumonia
2025
Overview
Community‑acquired pneumonia (CAP) still carries a high long‑term mortality. Free protoporphyrin in erythrocytes (FPP) is a well-recognized biomarker of erythropoietic porphyrias. However, it also reflects impaired heme synthesis, disturbances in iron metabolism, and inflammation-driven erythropoietic alterations, mechanisms particularly relevant in pneumonia. This pilot study aimed to evaluate, for the first time, the prognostic value of FPP and zinc protoporphyrin (ZnPP), measured in acetone extracts of erythrocytes using fluorescence analysis with 405 nm excitation, in predicting 100-day mortality among 66 patients hospitalized with CAP. The area under the ROC curve for FPP fluorescence in predicting mortality was 0.793 (95% CI 0.657–0.928;
p
< 0.0001), with 63% sensitivity and 94% specificity. Elevated FPP fluorescence was associated with a tenfold higher mortality risk and over fifteenfold greater odds of death, even after adjustment for age and the Charlson Comorbidity Index (CCI). A single fluorescence measurement at 632 nm (F632) demonstrated identical prognostic accuracy to spectral deconvolution-derived FPP intensity. Furthermore, significant correlations were observed between F632 or FPP fluorescence intensities and multiple clinical parameters reflecting disease severity, systemic inflammation, and erythropoietic stress. Given its accessibility and prognostic potential, prospective studies should further validate the method presented to guide individualized clinical management in CAP.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Aged
/ Anemia
/ Community-Acquired Infections - blood
/ Community-Acquired Infections - diagnosis
/ Community-Acquired Infections - mortality
/ Community-Acquired Pneumonia
/ COVID-19
/ Disease
/ Enzymes
/ Female
/ Free erythrocyte protoporphyrin
/ Humanities and Social Sciences
/ Humans
/ Hypoxia
/ Iron
/ Male
/ Patients
/ Protoporphyrins - metabolism
/ Science
/ Zinc
